precisionmedicineonline3d
McKesson Bets on Cell, Gene Therapy Products as it Corrals Services in New Business Unit
The pharmaceutical distributor has launched InspiroGene, a business unit offering logistics and other support for ...
Zacks.com on MSN3d
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
McKesson (MCK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...
ETF Daily News6d
Concurrent Investment Advisors LLC Decreases Holdings in McKesson Co. (NYSE:MCK)
It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions ...
McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network
We rate McKesson as a 'Strong Buy' with focus on GLP-1 meds, oncology network, and strong Q2 results driving future growth.
Fintel on MSN9d
Baird Upgrades McKesson (MCK)
Fintel reports that on November 7, 2024, Baird upgraded their outlook for McKesson (NYSE:MCK) from Neutral to Outperform. ...
McKesson’s Strong Q2 Performance Leads to Upward EPS Revision, But Hold Rating Due to Segment Concerns and Uncertain Long-Term Growth
Steve Baxter, an analyst from Wells Fargo, maintained the Hold rating on McKesson (MCK – Research Report). The associated price target ...
McKesson: Strong Q2 Performance and Raised FY 2025 Guidance Justify Buy Rating
McKesson (MCK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz ...
Benzinga.com9d
Spotlight on McKesson: Analyzing the Surge in Options Activity
Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company ...
Chicago Partners Investment Group LLC Buys 99 Shares of McKesson Co. (NYSE:MCK)
Chicago Partners Investment Group LLC increased its stake in shares of McKesson Co. (NYSE:MCK – Free Report) by 17.0% during ...
McKesson’s Broad-Based Growth Is Fueled by GLP-1s, New Customer, and Underpins Our Long-Term View
As of fiscal year-end 2024, McKesson had a cash and cash equivalents balance of $4.6 billion with an outstanding debt balance of $5.6 billion. Roughly one third of its debt is due to mature over the ...